Patent Assignment
Reel/Frame 049922/0697
Merger
Recorded: 2019-07-31
Pages: 6
Assignor
NUMAB INNOVATION AG
Executed: 2019-05-07
Assignee
NUMAB THERAPEUTICS AG
EINSIEDLERSTRASSE 34,, WADENSWIL, 8820, SWITZERLAND
Covered Properties
(4)
Novel Antibody Frameworks
Anti-TNFalpha-Antibodies and Functional Fragments Thereof
Hetero-Dimeric Multi-Specific Antibody Format
Novel Antibody Frameworks
Related Assignments
(8)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Mar 14, 2016
From: MEYER, SEBASTIAN; URECH, DAVID
To: NUMAB AG
Reel/Frame 037969/0036 →
Change of Name
Nov 22, 2017
From: NUMAB AG
To: NUMAB INNOVATION AG
Reel/Frame 044202/0688 →
Assignment of Assignor's Interest
Mar 17, 2018
From: URECH, DAVID; MEYER, SEBASTIAN
To: NUMAB INNOVATION AG
Reel/Frame 045263/0478 →
Change of Name
Oct 10, 2018
From: NUMAB AG
To: NUMAB INNOVATION AG
Reel/Frame 047119/0205 →
Assignment of Assignor's Interest
Oct 10, 2018
From: MEYER, SEBASTIAN; URECH, DAVID
To: NUMAB AG
Reel/Frame 047119/0128 →
Assignment of Assignor's Interest
Oct 16, 2018
From: GUNDE, TEA; MEYER, SEBASTIAN
To: NUMAB INNOVATION AG
Reel/Frame 047175/0642 →
Corrective Assignment to Correct the City of the Assignee from Wadenswil to WäDenswil Previously Recorded on Reel 049922 Frame 0697. Assignor(S) Hereby Confirms the Merger.
Aug 20, 2019
From: NUMAB INNOVATION AG
To: NUMAB THERAPEUTICS AG
Reel/Frame 050111/0212 →
Corrective Assignment to Correct the City of the Assignee Previously Recorded at Reel: 049922 Frame: 0697. Assignor(S) Hereby Confirms the Assignment.
Aug 25, 2019
From: NUMAB INNOVATION AG
To: NUMAB THERAPEUTICS AG
Reel/Frame 050160/0001 →